HemaSphere (Aug 2023)
P429: THERAPY-INDUCED SENESCENCE TRIGGERS UPREGULATION OF ANTIGEN PRESENTATION VIA PRC2 INHIBITION AND PROMOTES ANTI-TUMOUR IMMUNITY IN ACUTE MYELOID LEUKAEMIA
- Diego Gilioli,
- Simona Fusco,
- Teresa Tavella,
- Kety Giannetti,
- Anastasia Conti,
- Santoro Antonella,
- Edoardo Carsana,
- Stefano Beretta,
- Martin Schönlein,
- Valentina Gambacorta,
- Federico Aletti,
- Matteo Giovanni Carrabba,
- Chiara Bonini,
- Fabio Ciceri,
- Ivan Merelli,
- Luca Vago,
- Clemens A. Schmitt,
- Raffaella DI Micco
Affiliations
- Diego Gilioli
- 1 San Raffaele Hospital, Unit of Senescence in Stem Cell Aging, Differentiation and Cancer, San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Milan, Italy
- Simona Fusco
- 1 San Raffaele Hospital, Unit of Senescence in Stem Cell Aging, Differentiation and Cancer, San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Milan, Italy
- Teresa Tavella
- 1 San Raffaele Hospital, Unit of Senescence in Stem Cell Aging, Differentiation and Cancer, San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Milan, Italy
- Kety Giannetti
- 1 San Raffaele Hospital, Unit of Senescence in Stem Cell Aging, Differentiation and Cancer, San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Milan, Italy
- Anastasia Conti
- 1 San Raffaele Hospital, Unit of Senescence in Stem Cell Aging, Differentiation and Cancer, San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Milan, Italy
- Santoro Antonella
- 1 San Raffaele Hospital, Unit of Senescence in Stem Cell Aging, Differentiation and Cancer, San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Milan, Italy
- Edoardo Carsana
- 1 San Raffaele Hospital, Unit of Senescence in Stem Cell Aging, Differentiation and Cancer, San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Milan, Italy
- Stefano Beretta
- 2 National Research Council, Institute for Biomedical Technologies, Segrate, Italy
- Martin Schönlein
- 4 Charité - Universitätsmedizin, Medical Department of Hematology, Oncology and Tumor Immunology, Berlin, Germany
- Valentina Gambacorta
- 5 IRCCS San Raffaele Scientific Institute, Milano, Italy, Unit of Immunogenetics, Leukaemia Genomics and Immunobiology, Division of Immunology, Transplantation and Infectious Disease, Milan, Italy
- Federico Aletti
- 6 IRCCS San Raffaele Scientific Institute, Hematology and Bone Marrow Transplantation Unit, Milan, Italy
- Matteo Giovanni Carrabba
- 6 IRCCS San Raffaele Scientific Institute, Hematology and Bone Marrow Transplantation Unit, Milan, Italy
- Chiara Bonini
- 7 IRCCS San Raffaele Scientific Institute, Unit of Experimental Hematology, Division of Immunology, Transplantation and Infectious Disease, Milan, Italy
- Fabio Ciceri
- 6 IRCCS San Raffaele Scientific Institute, Hematology and Bone Marrow Transplantation Unit, Milan, Italy
- Ivan Merelli
- 2 National Research Council, Institute for Biomedical Technologies, Segrate, Italy
- Luca Vago
- 5 IRCCS San Raffaele Scientific Institute, Milano, Italy, Unit of Immunogenetics, Leukaemia Genomics and Immunobiology, Division of Immunology, Transplantation and Infectious Disease, Milan, Italy
- Clemens A. Schmitt
- 4 Charité - Universitätsmedizin, Medical Department of Hematology, Oncology and Tumor Immunology, Berlin, Germany
- Raffaella DI Micco
- 1 San Raffaele Hospital, Unit of Senescence in Stem Cell Aging, Differentiation and Cancer, San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Milan, Italy
- DOI
- https://doi.org/10.1097/01.HS9.0000968624.55051.32
- Journal volume & issue
-
Vol. 7
p. e5505132
Abstract
No abstracts available.